XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenues $ 25,562 $ 28,209
Research and development expenses 425,117 592,697
Selling and marketing expenses 125,343 308,637
General and administrative expenses 500,155 1,036,684
Total operating expenses 1,050,615 1,938,018
Operating loss 1,025,053 1,909,809
Financing income, net 3,400 62,015
Loss for the period 1,021,653 1,847,794
Other comprehensive income:    
Foreign currency translation loss (income) 33,148 (7,304)
Comprehensive loss for the period $ 1,054,801 $ 1,840,490
Loss per share (Basic and Diluted) $ 0.01 $ 0.34
Weighted average number of Common shares used in computing loss per share (Basic and Diluted) 143,615,503 7,021,533